The Effect of Gum Chewing on Postoperative Ileus After Gynecologic Surgery (GumGyn)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01579175
Recruitment Status : Completed
First Posted : April 17, 2012
Last Update Posted : March 14, 2013
Information provided by (Responsible Party):
Catherine Sewell, Johns Hopkins University

Brief Summary:
The investigators are randomizing patients to receive chewing gum (Extra Sugar Free, Spearment) every 4 hours during waking hours for 15 minutes versus standard postoperative care. The investigators then have them fill out a survey in house and 1 week after their surgery that record time to first flatus, hunger, toleration of clear liquids and food and some information about pain, satisfaction, and quality of life. The investigators contact them via phone and email a maximum of three times in order to collect this information. 30 days postoperatively the investigators also contact them and perform a chart review for any postoperative complications.

Condition or disease Intervention/treatment Phase
Postoperative Ileus Other: Chewing gum Phase 1 Phase 2

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 294 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: The Effect of Gum Chewing on Postoperative Ileus After Gynecologic Surgery.
Study Start Date : January 2010
Actual Primary Completion Date : February 2013
Actual Study Completion Date : February 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: After Surgery
U.S. FDA Resources

Arm Intervention/treatment
No Intervention: Standard postoperative care
Experimental: Chewing gum arm
Sugar free (extra, spearment) chewing gum given to the patient to chew during waking hours every four hours for 15 minutes
Other: Chewing gum
Sugar Free (Extra spearment) gum given to chew every 4 hours during waking hours for 15 minutes.
Other Name: Extra spearment sugar free gum

Primary Outcome Measures :
  1. Time to flatus [ Time Frame: 30 days ]

Secondary Outcome Measures :
  1. Postoperative ileus [ Time Frame: 30 days ]
    Nausea, vomiting, abdominal distention two episodes of 100cc of emesis

  2. time to discharge [ Time Frame: 30 days ]
  3. time to toleration of diet [ Time Frame: 30 days ]
  4. patient satisfaction [ Time Frame: 30 days ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • 18 years or older
  • Undergoing benign gynecologic surgery via an exploratory laparotomy
  • Capable of giving consent

Exclusion Criteria:

  • Oromaxillary or mental disturbances that would make chewing gum dangerous with regards to mastication or aspiration
  • Intubated or unconscious when leaving the OR
  • Bowel resection performed at the time of surgery
  • Active bowel disease (IBD, appendicitis, etc)
  • Gynecologic malignancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01579175

United States, Maryland
Johns Hopkins Bayview
Baltimore, Maryland, United States, 21224
Johns Hopkins Hospital
Baltimore, Maryland, United States, 21287
Sponsors and Collaborators
Johns Hopkins University
Principal Investigator: Catherine A Sewell, MD, MPH Johns Hopkins University
Study Chair: Amelia M Jernigan, MD Johns Hopkins University
Study Director: Grace Chen, MD Johns Hopkins Bayview

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Catherine Sewell, Principal Investigator, Johns Hopkins University Identifier: NCT01579175     History of Changes
Other Study ID Numbers: NA_00036423
First Posted: April 17, 2012    Key Record Dates
Last Update Posted: March 14, 2013
Last Verified: March 2013

Additional relevant MeSH terms:
Intestinal Obstruction
Intestinal Diseases
Gastrointestinal Diseases
Digestive System Diseases